Skip to main content
53°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Humacyte, Inc. - Common Stock
(NQ:
HUMA
)
1.490
-0.210 (-12.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Humacyte, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Humacyte Stock Continues Slide Despite Lower Than Expected Q4 Loss – But Retail Gets More Bullish
March 28, 2025
Fourth-quarter loss per share came in at $0.16, lower than the $0.24 in the corresponding period of 2023, and below the consensus estimate of $0.25, according to FinChat data.
Via
Stocktwits
Topics
Earnings
Exposures
Financial
Product Safety
Earnings Scheduled For March 28, 2025
March 28, 2025
Via
Benzinga
Humacyte Earnings Preview
March 27, 2025
Via
Benzinga
These stocks are moving in today's session
March 26, 2025
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Spotlight on Humacyte: Analyzing the Surge in Options Activity
December 20, 2024
Via
Benzinga
Peering Into Humacyte's Recent Short Interest
November 13, 2024
Via
Benzinga
Preview: Humacyte's Earnings
November 07, 2024
Via
Benzinga
(HUMA) - Analyzing Humacyte's Short Interest
October 21, 2024
Via
Benzinga
Keep an eye on the top gainers and losers in Wednesday's session.
March 26, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 26, 2025
Via
Benzinga
These stocks are gapping in today's session
March 26, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
How Is The Market Feeling About Humacyte?
September 05, 2024
Via
Benzinga
Why Humacyte (HUMA) Stock Is Falling Sharply
March 26, 2025
Humacyte shares are trading lower by 29% during Wednesday's session. The company priced a $50 million public offering.
Via
Benzinga
Top movers in Wednesday's pre-market session
March 26, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 26, 2025
Via
Benzinga
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 26, 2025
Via
Benzinga
US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert
March 26, 2025
U.S. stock futures were trading lower on Wednesday, after advancing for three consecutive sessions. Futures of major benchmark indices were lower in premarket trading.
Via
Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
March 26, 2025
Via
Benzinga
Top movers in Tuesday's after hours session
March 25, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 25, 2025
Via
Benzinga
Humacyte Shares Plunge After Hours: Here's Why
March 25, 2025
Humacyte shares are tumbling in Tuesday's after-hours session after the company announced a proposed public offering.
Via
Benzinga
Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday
December 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 20, 2024
Via
Benzinga
Dow Surges Over 600 Points, Gold Jumps 1.5%
December 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
December 20, 2024
Via
Benzinga
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
December 20, 2024
Via
Benzinga
Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday?
December 20, 2024
Humacyte's Symvess earns FDA approval as a first-in-class bioengineered vascular solution for urgent arterial injury repair in trauma cases.
Via
Benzinga
Exposures
Product Safety
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
December 20, 2024
Via
Benzinga
US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone'
December 20, 2024
U.S. futures declined on Friday, ahead of the 'Triple Witching' hour, which is expected to see $6.6 trillion options expire, for the quarter.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 17, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.